Madrigal Pharmaceuticals Inc. logo

Madrigal Pharmaceuticals Inc.

MDGL | NASDAQ
Chart Builder DCF Calculator
$522.19
+$0.23 (+0.04%)
Sep 22, 2026, 12:44 PM ET · Market open
Fiscal Year
Period Ending
FY 2025
Dec 30, 2025
FY 2024
Dec 30, 2024
FY 2023
Dec 30, 2023
FY 2022
Dec 30, 2022
FY 2021
Dec 30, 2021
FY 2020
Dec 30, 2020
Cash & Equivalents
198.69M 100.02M 99.92M 331.55M 36.27M 54M
Short-Term Investments
784.87M 826.23M 534.22M 27.23M 234.08M 230.15M
Long-Term Investments
n/a n/a n/a n/a n/a n/a
Other Long-Term Assets
n/a n/a n/a n/a n/a n/a
Receivables
134.48M 53.82M n/a n/a n/a n/a
Inventory
74.84M 34.07M n/a n/a n/a n/a
Other Current Assets
52.89M 18.79M 3.15M 2.6M n/a n/a
Total Current Assets
1.25B 1.03B 637.28M 361.37M 271.68M 285.16M
Property-Plant & Equipment
6.44M 4.59M 3.27M 1.2M 1.65M 1.83M
Goodwill & Intangibles
7.38M 4.73M n/a n/a n/a n/a
Total Long-Term Assets
13.82M 9.32M 3.27M 1.2M 1.65M 1.83M
Total Assets
1.26B 1.04B 640.55M 362.57M 273.33M 287M
Account Payables
48.88M 43.6M 28.04M 23.83M 21.38M 1.02M
Deferred Revenue
n/a n/a n/a n/a n/a n/a
Short-Term Debt
1.02M n/a n/a n/a n/a n/a
Other Current Liabilities
260.39M 34.96M 17.03M 14.86M 6.77M 4.69M
Total Current Liabilities
310.29M 169.28M 118.55M 115.89M 76.84M 46.56M
Long-Term Debt
346.61M 117.57M 115.48M 49.29M n/a n/a
Other Long-Term Liabilities
-6.73M n/a n/a n/a n/a n/a
Total Long-Term Liabilities
346.61M 118.59M 116.67M 49.29M 387K 468K
Total Liabilities
656.9M 287.86M 235.21M 165.18M 77.23M 47.03M
Total Debt
354.36M 119.57M 117.19M 49.89M 797K 786K
Book Value
602.69M 754.38M 405.33M 197.39M 196.11M 239.97M
Book Value Per Share
26.86 35.46 21.69 11.52 11.86 15.54
Common Stock
2K 2K 2K 2K 2K 2K
Retained Earnings
-2.09B -1.8B -1.34B -962.66M -667.31M -425.46M
Comprehensive Income
873K 468K 468K -32K -80K 47K
Shareholders Equity
602.69M 754.38M 405.33M 197.39M 196.11M 239.97M
Total Investments
784.87M 826.23M 534.22M 27.23M 234.08M 230.15M

© 2026 bestshares.com. All rights reserved.